Prothena's anti-amyloid therapy receives FDA fast track designation to treat Alzheimer’s
BioPharma-Reporter - 03-May-2022Guarantees higher efficacy, convenience and potential safety than other anti-Aβ therapies
Join the club for FREE to access the whole archive and other member benefits.
News on drugs, vaccines and regenerative medicines
BioPharma-Reporter is the leading online news source for the biopharma industry for more than 8 years, leveraging our digital-first position to bring powerful insights and robust information to help business succeed. The website updates news and analysis on the clinical development and manufacture of large molecule drugs, vaccines and regenerative medicines. It offers 360-degree coverage of the bioprocessing world, providing biopharma professionals news focused on clinical trials, commercial development and manufacture of large molecule drugs, vaccines, live biotherapeutics and advanced therapeutics.
Visit website: https://www.biopharma-reporter.com/
Details last updated 03-Jul-2023
Guarantees higher efficacy, convenience and potential safety than other anti-Aβ therapies
French biotech Seekyo secures funding for a tumour-targeting chemotherapy drug